Filtered By:
Management: Medicaid
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 7664 results found since Jan 2013.
Patient Predictors of Hospitalization for Pediatric Migraine (P6.335)
Conclusions Our data suggest racial and socioeconomic differences in treatment of migraine, known to be present in adults, are also observed in pediatric datasets. Contributing factors may include differences in migraine features, cultural perception of pain, disparities in access and quality of care. Efforts to reduce disparities in migraine disability may need to consider the early evolution of disparities in treatment and care.Disclosure: Dr. Patel has nothing to disclose. Dr. Thibault has nothing to disclose. Dr. Willis has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Patel, P., Thibault, D., Willis, A. Tags: Child Neurology and Developmental Neurology: Other Source Type: research
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
CONCLUSION: In consideration of the migraine-specific acute medications used in FFS Medicaid 2020, for patients using CGRP mAbs for prevention, medication costs may vary significantly with the number of breakthrough attacks treated per month and the type of migraine-specific acute therapy used.PMID:36648736 | DOI:10.1007/s12325-022-02386-w
Source: Adv Data - January 17, 2023 Category: Epidemiology Authors: Linda Harris Tom O'Connell Jonathan J Woolley Gilbert L'Italien Tamela Martin Vladimir Coric James A Moren Source Type: research
Hazard of substance abuse onset among adults diagnosed with epilepsy or migraine
Epilepsy Behav. 2023 May 18;144:109258. doi: 10.1016/j.yebeh.2023.109258. Online ahead of print.ABSTRACTOBJECTIVE: We investigated adult-onset epilepsy as a risk factor for the development of substance use disorder (SUD) by comparing the rate of SUD diagnosis among adults diagnosed with epilepsy with presumably healthy controls with lower extremity fractures (LEF). For additional comparison, we investigated the risk for adults with migraine only. Epilepsy and migraine are both episodic neurological disorders and migraine is frequently comorbid with epilepsy.METHODS: We conducted a time-to-event analysis using a subset of s...
Source: Epilepsy and Behaviour - May 20, 2023 Category: Neurology Authors: Stephanie K Jones Jeffrey E Korte Dulaney Wilson Source Type: research
National Trends in Hospitalizations of Migraine in the United States, 2002-2012 (P1.157)
Conclusion There was a significant increase in the rate of migraine hospitalizations between 2002 and 2012. Despite stable hospital LOS and no change in trend of diagnostic procedures, total hospital charges attributable to these admissions grew dramatically. A greater focus on quality headache services are needed to avoid costly hospitalizations.Disclosure: Dr. Taherian has nothing to disclose. Dr. Monteith has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Taherian, M., Monteith, T. Tags: Headache: Health Services/Outcomes Research, Genetics, and Therapeutics Source Type: research
Adherence to Oral Migraine Preventive Medications Among Patients with Chronic Migraine: Analysis of a Large US Health Insurance Claims Database (S41.009)
CONCLUSIONS:Adherence to oral migraine preventive medications is low among the US chronic migraine population at 6 months and declines even further by 12 months. Further research evaluating reasons for non-adherence, and strategies to improve adherence, is needed.Study Supported by: Allergan Inc.Disclosure: Dr. Hepp has nothing to disclose. Dr. Dodick has received personal compensation for activities with Allergan, Inc., Pfizer Inc., Merck & Co., Inc., ENeura NuPathe, Colucid, Alder, Artaeus, Eli Lilly & Company, Amgen Inc., WL Gore, Bristol-Myers Squibb Company, Ethicon J&J, ATI, Zogenix, Cognimed, Intramed, S...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hepp, Z., Dodick, D., Varon, S., Gillard, P., Hansen, R., Devine, E. Tags: Headache: Clinical Source Type: research
Adherence to Oral Migraine Preventive Medications Among Patients with Chronic Migraine: Analysis of a Large US Health Insurance Claims Database (I8-1.006)
CONCLUSIONS:Adherence to oral migraine preventive medications is low among the US chronic migraine population at 6 months and declines even further by 12 months. Further research evaluating reasons for non-adherence, and strategies to improve adherence, is needed.Study Supported by: Allergan Inc.Disclosure: Dr. Hepp has nothing to disclose. Dr. Dodick has received personal compensation for activities with Allergan, Inc., Pfizer Inc., Merck & Co., Inc., ENeura NuPathe, Colucid, Alder, Artaeus, Eli Lilly & Company, Amgen Inc., WL Gore, Bristol-Myers Squibb Company, Ethicon J&J, ATI, Zogenix, Cognimed, Intramed, S...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hepp, Z., Dodick, D., Varon, S., Gillard, P., Hansen, R., Devine, E. Tags: Clinical Decision Making After the Dust Settles on Clinical Trials Poster Presentations Source Type: research
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
ConclusionIn consideration of the migraine-specific acute medications used in FFS Medicaid 2020, for patients using CGRP mAbs for prevention, medication costs may vary significantly with the number of breakthrough attacks treated per month and the type of migraine-specific acute therapy used.
Source: Advances in Therapy - January 17, 2023 Category: Drugs & Pharmacology Source Type: research
Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.
CONCLUSION: There are many barriers and challenges that affect people with migraine who are underinsured or uninsured, particularly those of under-represented racial backgrounds and of lower socioeconomic status.
PMID: 29516470 [PubMed - as supplied by publisher]
Source: Headache - March 8, 2018 Category: Neurology Authors: Charleston L, Royce J, Monteith TS, Broner SW, O'Brien HL, Manrriquez SL, Robbins MS Tags: Headache Source Type: research
The Real-World Impact of OnabotulinumtoxinA on Headache-Related ER Visits and Hospitalizations in the Management of Chronic Migraine (S23.004)
CONCLUSIONS: Prophylactic use of onabotulinumtoxinA significantly reduced headache-related ER visits and hospitalizations in the general CM population. Support:AllerganDisclosure: Dr. Hepp has received personal compensation for activities with Allergan, Inc. as an employee. Dr. Rosen has nothing to disclose. Dr. Varon has received personal compensation for activities with Allergan, Inc. Dr. Gillard has received personal compensation for activities with Allergan, Inc. as an employee. Dr. Chia has received personal compensation for activities with Allergan as an employee. Dr. Mathew has received personal compensation for act...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Hepp, Z., Rosen, N., Varon, S., Gillard, P., Chia, J., Mathew, N., Dodick, D. Tags: Headache: Epidemiology and Clinical Source Type: research
Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1
ConclusionThere are many barriers and challenges that affect people with migraine who are underinsured or uninsured, particularly those of under‐represented racial backgrounds and of lower socioeconomic status.
Source: Headache: The Journal of Head and Face Pain - March 8, 2018 Category: Neurology Authors: Larry Charleston, Jeffrey Royce, Teshamae S. Monteith, Susan W. Broner, Hope L. O'Brien, Salvador L. Manrriquez, Matthew S. Robbins Tags: Review Article Source Type: research
Trends in utilization and costs of migraine medications, 2017 –2020
ConclusionOur study demonstrates a shift in migraine medication utilization from 2017 –2020, where increased use of CGRP mABs had a significant contribution to increased costs. These increased pharmacy costs must be weighed against the improved tolerability of these agents likely resulting in other healthcare and indirect cost savings.
Source: The Journal of Headache and Pain - August 28, 2022 Category: Neurology Source Type: research
Health care resource utilizations and costs among migraine patients in the u.s. Medicaid population
To examine the health care resource utilizations and costs among migraine patients in the U.S. Medicaid population.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: A Huang, S Shrestha, O Baser, H Yuce, L Wang Source Type: research
The Search for the Elusive Elixir of Life
By TOM EMERICK
Here’s the executive summary: Most disease and health spending is age-related. As we age we get infirmities ranging from dementia to cancer to vascular disease. Nothing can prevent aging. Period. For millennia mankind has been been on a futile search to prevent aging.
Search for the Elusive Elixir of Life
For 3500 or more years mankind has been searching for the mythological Elixir of Life, the fountain of youth, the philosophers stone, pool of nectar, etc, that will defeat aging and extend life, if not achieve immortality.
According to Wiki, “The elixir of life, also known as the elixir of immortality a...
Source: The Health Care Blog - February 4, 2016 Category: Consumer Health News Authors: Simon Nath Tags: THCB Tom Emerick Source Type: blogs
Physician Payments Sunshine Act: CMS Extends Data Correction to October 31, Corrected Payments Will Be Published “On or Before December 31;” Open Payments Search Tool Launched
The Centers for Medicare and Medicaid Services (CMS) made a number of announcements related to their Open Payments system this afternoon. The Open Payments website now has a search tool by physician name, teaching hospital, and company. CMS also announced that industry should correct disputed 2013 data by October 31 for corrections to be published on or before December 31, 2014. CMS also addressed de-identified data. Industry will soon be able to edit the de-identified payments, and will then go through a review and dispute period with covered recipients.
Industry: Correct Disputed 2013 Data by October 31
By close of busin...
Source: Policy and Medicine - October 17, 2014 Category: American Health Authors: Thomas Sullivan Source Type: blogs
Open Payments Search Tool Now Includes Summary Information about Companies and Doctors; CMS releases Updated Physician Matching List
The Centers for Medicare and Medicaid Services (CMS) today made a number of announcements related to the Open Payments program.
Updates to the physician and manufacturer search tool
CMS previously announced the availability of the Open Payments data search tool to allow users to search identified data for physicians, teaching hospitals, or companies making payments by name, city, state, and specialty. Now, they have enhanced their search tool so that when users search for physicians, teaching hospitals, or companies making payments, they can view detailed and new summary information about them.
This new ...
Source: Policy and Medicine - December 4, 2014 Category: American Health Authors: Thomas Sullivan Source Type: blogs
